The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Klarkowski, Derryck B ^a   Wazome, Joseph M ^a   Lokuge, Kamalini M ^a   Shanks, Leslie ^a   Mills, Clair F ^a   O'Brien, Daniel P ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

ALGORITHM; ARTICLE; BLOOD SAMPLING; CONGO; CONTROLLED STUDY; DIAGNOSTIC TEST; FALSE POSITIVE RESULT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IN SITU HUMAN IMMUNODEFICIENCY VIRUS CONFIRMATION TEST; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; WESTERN BLOTTING; WORLD HEALTH ORGANIZATION;

EID: 84859147651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004351     Document Type: Article

References (34)

1. Programme National de Lutte contra le VIH/SIDA et les ISTs. Rapport du passage de la surveillance sentinelle du VIH chez les femmes enceinte frequentant les services de CPN. Kinshasa, 2003-04.
2. World Health Organization Rapid HIV Tests (2004) Guidelines for use in HIV testing and counselling services in resource-constrained settings.
3. Chanbancherd P, Jugsudee A, Thanomklom S, Limpairojn N, Julananto P, et al. (1999) Frequency of HIV false positivity from two sequential enzyme immunoassays in 111 639 sera. AIDS 13(15): 2182-3.
4. Sudha T, Lakshmi V, Teja VD (2006) Western blot profile in HIV infection. Indian J Dermatol Venereol Leprol 72(5): 357-60.
5. Ngan CC, Thoe SY, Chan KP, Sng JE, Ling AE (2002) Alternative strategies for confirmation of human immunodeficiency virus infection require judicious use. J Clin Microbiol 40(1): 314-5.
6. Singer DE, Kiwanuka N, Serwadda D, Nalugoda F, Hird L, et al. (2005) Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays. J Clin Microbiol 43(10): 5312-5.
7. Granade TC, Parekh BS, Tih PM, Welty T, Welty E, et al. (2005) Evaluation of rapid prenatal human immunodeficiency virus testing in rural Cameroon. Clin Diagn Lab Immunol 12(7): 855-60.
8. Meles H, Wolday D, Fontanet A, Tsegaye A, Tilahun T, et al. (2002) Indeterminate human immunodeficiency virus Western blot profiles in Ethiopians with discordant screening-assay results. Clin Diagn Lab Immunol 9(1): 160-3.
9. Aidoo S, Ampofo WK, Brandful JA, Nuvor SV, Ansah JK, et al. (2001) Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa. J Clin Microbiol 39(7): 2572-5.
10. Thakral B, Saluja K, Sharma RR, Marwaha N (2006) Algorithm for recall of HIV reactive Indian blood donors by sequential immunoassays enables selective donor referral for counseling. J Postgrad Med 52(2): 106-9.
11. Gray RH, Makumbi F, Serwadda D, Lutalo T, Nalugoda F, et al. (2007) Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ. 335(7612): 188.
12. Culbert H, Tu D, O'Brien DP, Ellman T, Mills C, et al. (2007) HIV Treatment in a Conflict Setting: Outcomes and Experiences from Bukavu, Democratic Republic of the Congo. PLoS Med 4(5): e129. doi:10.1371/ journal.pmed.0040129.
13. Centers for Disease Control (1989) Interpretation and use of the Western blot assay for serodiagnosis of Human Immunodeficiency Virus Type 1 infections. MMWR 38(S-7): 1-7.
14. Agence Nationale d'Accréditation et d'Evaluation en Santé. Stratégies du diagnostic biologique de l'infection due au VIH chez les sujets ages de plus de 18 mois (à l'exclusion du dépistage sur les dons de sang et chez les donneurs d'organes ou de tissus): January. 2000.
15. Ng VL (1991) Serological diagnosis with recombinant peptides/proteins. Clin Chem 37(10 Pt 1): 1667-8.
16. Foglia G, Royster GD 4th, Wasunna KM, Kibaya R, Malia JA, et al. (2004) Use of rapid and conventional testing technologies for human immunodeficiency virus type 1 serologic screening in a rural Kenyan reference laboratory. J Clin Microbiol 42(8): 3850-2.
17. Jafa K, Patel P, MacKellar DA, Sullivan PS, Delaney KP, et al. (2007) Investigation of False Positive Results with an Oral Fluid Rapid HIV-1/2 Antibody Test. PLoS ONE 2(1): e185. doi:10.1371/journal.pone.0000185.
18. Branson BM (2003) Point-of-care rapid tests for HIV antibodies. J Lab Med 27(7/8): 288-295.
19. Ramalingam S, Kannangai R, Raj AA, Jesudason MV, Sridharan G (2002) Rapid particle agglutination test for human immunodeficiency virus: hospital-based evaluation. J Clin Microbiol 40: 1553-1554.
20. Elm J D, Diwan A (1998) Serological cross-reactivities between the retroviruses HIV and HTLV-1 and the malaria parasite Plasmodium falciparum. PNG Med J 41(1): 15-22.
21. Urassa W, Godoy K, Killewo J, Kwesigabo G, Mbakileki A, et al. (1999) The accuracy of an alternative confirmatory strategy for detection of antibodies to HIV-1: experience from a regional laboratory in Kagera, Tanzania. J Clin Virol 14(1): 25-9.
22. Kleinman S, Busch MP, Hall L, Thomson R, Glynn S, et al. (1998) False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study. JAMA 280(12): 1080-5.
23. Gasasira AF, Dorsey G, Kamya MR, Havlir D, Kiggundu M, et al. (2006) False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria. J Clin Microbiol 44(8): 3021-4.
24. Healey DS, Bolton WV (1993) Apparent HIV-1 glycoprotein reactivity on western blot in uninfected blood donors. AIDS 7(5): 655-8.
25. Sayre KR, Dodd RY, Tegtmeier G, Layug L, Alexander SS, et al. (1996) False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors. Transfusion 36: 45-52.
26. Celum CL, Coombs RW, Jones M, Murphy V, Fisher L, et al. (1994) Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control study. Arch Intern Med 154(10): 1129-37.
27. Thomas HI, Wilson S, O'Toole CM, Lister CM, Saeed AM, et al. (1996) Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Clin Exp Immunol 103(2): 185-91.
28. Craske J, Turner A, Abbott R, Collier M, Gunson HH, et al. (1990) Comparison of false-positive reactions in direct-binding anti-HIV ELISA using cell lysate or recombinant antigens. Vox Sang 59(3): 160-6.
29. Hill AV, Allsopp CE, Kwiatkowski D, Taylor TE, Yates SN, et al. (1992) Extensive genetic diversity in the HLA class II region of Africans, with a focally predominant allele, DRB1*1304. Proc Natl Acad Sci U S A 89(6): 2277-81.
30. Alves C, Souza T, Meyer I, Toralles MB, Brites C (2006) Immunogenetics and infectious diseases: special reference to the mayor histocompatibility complex. Braz J Infect Dis 10(2): 122-31.
31. Barthel HR, Wallace DJ (1993) False-positive human immunodeficiency virus testing in patients with lupus erythematosus. Semin Arthritis Rheum 23(1): 1-7.
32. Clerici M, Butto S, Lukwiya M, Declich S, Trabattoni D, et al. (2000) Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project. AIDS 14(14): 2083-92.
33. Clerici M, Declich S, Rizzardini G (2001) African enigma: key player in human immunodeficiency virus pathogenesis in developing countries? Clin Diagn Lab Immunol 8(5): 864-6.
34. Messele T, Abdulkadir M, Fontanet AL, Petros B, Hamann D, et al. (1999) Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin Exp Immunol 115(3): 443-50.